Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Drug Prescriptions | 2 | 2018 | 1062 | 0.74 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 711 | 0.51 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.45 | Why? |
| Immunization | 1 | 2018 | 2019 | 0.37 | Why? |
| Critical Pathways | 1 | 2018 | 1587 | 0.34 | Why? |
| Feces | 2 | 2020 | 4235 | 0.33 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.29 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.29 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.27 | Why? |
| Immunocompromised Host | 2 | 2020 | 5150 | 0.27 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.21 | Why? |
| Methicillin | 1 | 2020 | 73 | 0.21 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.17 | Why? |
| Enterocolitis, Necrotizing | 1 | 2017 | 71 | 0.16 | Why? |
| Infant | 8 | 2021 | 30274 | 0.16 | Why? |
| Rectum | 1 | 2020 | 495 | 0.16 | Why? |
| Child | 12 | 2021 | 70012 | 0.15 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.14 | Why? |
| beta-Lactamases | 1 | 2020 | 759 | 0.13 | Why? |
| Infant, Newborn | 6 | 2021 | 23105 | 0.12 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.12 | Why? |
| Italy | 7 | 2021 | 38444 | 0.11 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.11 | Why? |
| Organizational Policy | 1 | 2017 | 694 | 0.11 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.11 | Why? |
| Intensive Care Units, Neonatal | 1 | 2017 | 749 | 0.11 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.10 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Vaccination Coverage | 1 | 2018 | 1249 | 0.09 | Why? |
| Communicable Disease Control | 1 | 2018 | 29620 | 0.09 | Why? |
| Risk | 1 | 2020 | 5288 | 0.09 | Why? |
| Malaria | 1 | 2017 | 1097 | 0.08 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.07 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.07 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.07 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.06 | Why? |
| Humans | 15 | 2021 | 930598 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Vaccines | 1 | 2018 | 3692 | 0.05 | Why? |
| Travel | 1 | 2017 | 7220 | 0.04 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Adult | 4 | 2021 | 244371 | 0.04 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Male | 5 | 2020 | 367725 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Female | 5 | 2020 | 380317 | 0.03 | Why? |
| Chemoprevention | 1 | 2017 | 585 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Data Collection | 1 | 2021 | 1769 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.03 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2020 | 1792 | 0.02 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.02 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Aged | 2 | 2020 | 215776 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.02 | Why? |
| Antimalarials | 1 | 2017 | 2505 | 0.02 | Why? |
| Middle Aged | 2 | 2020 | 270681 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2020 | 3630 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |